Trial intelligence / Profile preview

PEDRIX: Cligosiban in lifelong premature ejaculation

NCT03055806Phase 2Completed

Sponsor
Ixchelsis
Start
Feb 2017
Primary completion
Nov 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of cligosiban in premature ejaculation (PE), sponsored by Ixchelsis. Started Feb 2017; status: completed.

02

Drugs

cligosiban
03

Conditions

premature ejaculation (PE)

Beyond the preview

Go deeper on NCT03055806.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03055806.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call